Magnetic-Targeted Doxorubicin in Treating Patients With Cancer Metastatic to the Liver

Clinical trial NCT00041808 · COMPLETED

Trial details

NCT number: NCT00041808
Sponsor: FeRx
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Metastases, Neoplasm Colorectal Neoplasms Esophageal Neoplasms Stomach Neoplasms Pancreatic Neoplasms Breast Neoplasms Melanoma Sarcoma Gastrointestinal Neoplasms Lung Neoplasms Liver Neoplasms Cholangiocarcinoma

Start date: 2001-07-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.